Cerecor Inc. – NASDAQ:CERC

Founder-led company

Cerecor stock price today

$2.93
-1.6
-35.32%

Cerecor stock price monthly change

+54.61%
month

Cerecor stock price quarterly change

+54.61%
quarter

Cerecor stock price yearly change

+48.04%
year

Cerecor key metrics

Market Cap
 38.62M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Cerecor stock price history

Cerecor stock forecast

Cerecor financial statements

Quarterly Earnings

Cerecor Inc. (NASDAQ:CERC): Earnings per share (EPS)
2021-08-02 -0.18 -0.18
CERC earnings history

Cerecor alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Cerecor
Employees

Cerecor Inc. (NASDAQ:CERC): Employee count
Aug 2023 30
Sep 2023 30
Oct 2023 30
Nov 2023 30
Dec 2023 30
Jan 2024 30
Feb 2024 30
Mar 2024 30
Apr 2024 30
May 2024 30
Jun 2024 30
Jul 2024 30
Dec 2024 30

Cerecor other data

Cerecor
Insider Trading

Cerecor Inc. (NASDAQ:CERC): Insider trades (number of shares)
Period Buy Sel
Nov 2020 100000 0
Dec 2020 28865 0
Jan 2021 2500000 0
May 2021 180000 0
Jun 2021 12749 0
Aug 2021 200000 0
Sep 2021 5700000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
ARMISTICE CAPITAL, LLC director, 10 percent owner
 Common Stock 5,454,545 $2.2 $11,999,999
Purchase
ARMISTICE CAPITAL, LLC director, 10 percent owner
 Common Stock 150,000 $2.28 $342,000
Purchase
ARMISTICE CAPITAL, LLC director, 10 percent owner
 Common Stock 95,455 $2.26 $215,919
Purchase
ARMISTICE CAPITAL, LLC director, 10 percent owner
 Common Stock 20,000 $2.78 $55,560
Purchase
ARMISTICE CAPITAL, LLC director, 10 percent owner
 Common Stock 30,000 $2.76 $82,650
Purchase
ARMISTICE CAPITAL, LLC director, 10 percent owner
 Common Stock 25,000 $2.83 $70,625
Purchase
ARMISTICE CAPITAL, LLC director, 10 percent owner
 Common Stock 25,000 $2.83 $70,625
Purchase
ARMISTICE CAPITAL, LLC director, 10 percent owner
 Common Stock 100,000 $2.69 $268,600
Purchase
WILKINS H JEFFREY Common Stock 912 N/A N/A
Purchase
WILKINS H JEFFREY Common Stock 912 N/A N/A
CERC insider trading transactions

Cerecor
Patents

Patent
Application
Filling date: 18 Mar 2020 Issue date: 2 Jun 2022
Application
Filling date: 7 Jan 2019 Issue date: 13 May 2021
Application
Filling date: 27 May 2020 Issue date: 15 Apr 2021
Application
Filling date: 19 Jun 2020 Issue date: 8 Apr 2021
Grant
Filling date: 16 Nov 2016 Issue date: 18 Aug 2020
Grant
Filling date: 11 Feb 2019 Issue date: 14 Jul 2020
CERC patents

Cerecor
Executives

Insider Compensation
Dr. Garry A. Neil (1954) Chief Scientific Officer $705,480
Dr. H. Jeffery Wilkins M.D. (1962) Chief Medical Officer $547,420
Mr. Michael F. Cola (1960) Chief Executive Officer, Pres & Director $464,990
Dr. Lisa Hegg Vice President of R&D Programs and Project Management
Mr. Christopher Ryan Sullivan Chief Accounting Officer & Principal Accounting Officer
Mr. Schond L. Greenway Chief Financial Officer, Principal Financial Officer & Treasurer
Dr. Solomon H. Snyder Founder and Chairman of Scientific Advisory Board
Dr. Barbara S. Slusher Founder and Member of Scientific Advisory Board
Mr. James Archie Harrell Jr. Chief Commercial Officer
Dr. Younok Dumortier Shin M.B.A., Ph.D. Chief Technology Officer

Frequently Asked Questions (FAQ)

  • What's the price of Cerecor stock today?

    One share of Cerecor stock can currently be purchased for approximately $2.93.

  • When is Cerecor's next earnings date?

    Unfortunately, Cerecor's (CERC) next earnings date is currently unknown.

  • Does Cerecor pay dividends?

    No, Cerecor does not pay dividends.

  • How much money does Cerecor make?

    Cerecor has a market capitalization of 38.62M.

  • What is Cerecor's stock symbol?

    Cerecor Inc. is traded on the NASDAQ under the ticker symbol "CERC".

  • What is Cerecor's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Cerecor?

    Shares of Cerecor can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Cerecor's key executives?

    Cerecor's management team includes the following people:

    • Dr. Garry A. Neil Chief Scientific Officer(age: 71, pay: $705,480)
    • Dr. H. Jeffery Wilkins M.D. Chief Medical Officer(age: 63, pay: $547,420)
    • Mr. Michael F. Cola Chief Executive Officer, Pres & Director(age: 65, pay: $464,990)
    • Dr. Lisa Hegg Vice President of R&D Programs and Project Management
    • Mr. Christopher Ryan Sullivan Chief Accounting Officer & Principal Accounting Officer
    • Mr. Schond L. Greenway Chief Financial Officer, Principal Financial Officer & Treasurer
    • Dr. Solomon H. Snyder Founder and Chairman of Scientific Advisory Board
    • Dr. Barbara S. Slusher Founder and Member of Scientific Advisory Board
    • Mr. James Archie Harrell Jr. Chief Commercial Officer
    • Dr. Younok Dumortier Shin M.B.A., Ph.D. Chief Technology Officer

  • Is Cerecor founder-led company?

    Yes, Cerecor is a company led by its founders Dr. Solomon H. Snyder and Dr. Barbara S. Slusher.

  • How many employees does Cerecor have?

    As Dec 2024, Cerecor employs 30 workers.

  • When Cerecor went public?

    Cerecor Inc. is publicly traded company for more then 9 years since IPO on 13 Nov 2015.

  • What is Cerecor's official website?

    The official website for Cerecor is cerecor.com.

  • Where are Cerecor's headquarters?

    Cerecor is headquartered at 540 Gaither Rd Ste 400, Rockville, MARYLAND.

  • How can i contact Cerecor?

    Cerecor's mailing address is 540 Gaither Rd Ste 400, Rockville, MARYLAND and company can be reached via phone at +1 410 522 8707.

Cerecor company profile:

Cerecor Inc.

cerecor.com
Exchange:

NASDAQ

Full time employees:

30

Industry:

Biotechnology

Sector:

Healthcare

Cerecor Inc., a biopharmaceutical company, focuses on development and commercialization of treatments for rare pediatric and orphan diseases. It develop therapies for the treatment of inherited metabolic disorders, such as CERC-801 and CERC-802, which completed the phase I clinical trial; and CERC-803. The company is also involved in the developing of CERC-007, an anti-IL-18 monoclonal antibody for the treatment of autoimmune inflammatory diseases, such as adult onset stills disease and multiple myeloma; CERC-006, a dual mTOR inhibitor to treat complex lymphatic malformations; and CERC-002, an anti-LIGHT monoclonal antibody for the treatment of Pediatric-onset Crohn's diseases. In addition, it develops CERC-913, a protide nucleotide for the treatment of mitochondrial disorder; CERC-005, a monoclonal antibody to treat rare auto-inflammatory diseases; CERC-301 for the treatment of symptomatic Orthostatic Hypotension; and CERC-406 for the treatment of Parkinson's disease. Further, the company offers Millipred, an oral prednisolone for the treatment of inflammatory conditions, such as arthritis, blood disorders, immune system disorders, skin and eye conditions, respiratory disorders, cancer, and severe allergies. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.

+1 410 522 8707
540 Gaither Rd Ste 400
Rockville, MARYLAND 20850

CIK: 0001534120
ISIN: US15671L1098
CUSIP: 15671L109